Education
In this month's "Hot Topic," Elitza Theel, Ph.D., will be discussing laboratory utilization management, specifically for diagnostic testing for tick-borne diseases.
The considerations physicians must weigh when evaluating suspected neuropathy patients with special emphasis put on small-fiber neuropathy and the most appropriate laboratory testing related to that phenotype.
Saliva testing has emerged as a viable option for obtaining rapid, reliable test results during the COVID-19 pandemic. Mayo Clinic’s Dr. Darci Block considers how this type of testing may expand beyond the pandemic, and the obstacles in its way.
The Specimens Operations team at Mayo Clinic Laboratories is dedicated to ensuring that patient samples reach the labs quickly and safely. Get an inside look at how they accomplish that crucial goal for more than 40,000 specimens every day.
This “Phlebotomy Webinar” covers real-life challenging scenarios that arise in the clinical setting. Four unique case studies are presented, and suggestions are discussed on how to help and respond in these situations to support the pediatric patient.
This "Phlebotomy Webinar" will enhance the user’s knowledge regarding how the secrets of magicians can be used to reduce patient fear and anxiety associated with hospital and clinic visits. Attendees will be provided with research studies and rationale for using magic tricks and similar techniques to decrease exam length and possibly sedation needed during radiography exams. Visual examples of concepts will be demonstrated to ensure complete understanding. A variety of tools and recommendations will be offered to fit every health care worker’s comfort level. The goal of the presentation is to provide information that will improve the overall patient experience, as well as make the job of the care provider easier and more enjoyable.
In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the modified two-tiered testing algorithm for Lyme disease entirely based on enzyme immunoassays (EIA).
This "Phlebotomy Webinar" presentation will review the methods available to detect latent infection with Mycobacterium tuberculosis, or latent tuberculosis infection (LTBI), including the classic tuberculin skin test and the more recently developed interferon gamma release assays (IGRA).
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses a recent change to the direct immunofluorescence assay, specifically the addition of the IgG4 conjugate.
The discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
This "Phlebotomy Webinar" presentation highlights the most common pre-analytical variables encountered in the hospital setting that may compromise blood specimen integrity and lead to specimen recollection.
Update your bookmark! Dangerous Goods can now be found at https://news.mayocliniclabs.com/dangerous-goods-training/